Download Docs
Export
Print

THETA

99591519 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Jan. 13, 2026
Serial No. 99591519
Examining Attorney DANIEL LEE FLINT
Class Pharmaceutical preparations for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors; Drug delivery agents consisting of antibodies or antibody fragments, sold as an integral component of pharmaceuticals; Antibodies and antibody fragments for therapeutic purposes; Antibody-drug conjugates for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors; Antibody fragment-drug conjugates for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors; 005; 006; 018; 044; 046; 051; 052; 100; 101
THETA
Case Type Trademark Service mark
Status Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Last Updated: 16 hours ago
Filing Date # Docket Text
to view the full docket.